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Mass poisonings of the public are often food-borne
. a
s
recently demonstrated by the Spanish toxic oil sy ndrome, an
epidemic in which hundreds died and thousands became ill
(1-13) . Although most of the ill patient, have recovered
.
some remain chronically disabled and some deaths continue
to occuras a result of the initial toxic exposure . Peen though
vascular lesions were recognized early after the large group
of initial deaths and the likelihood of fundamental endothe-
lial lesions was emphasized (8) . there hzs been little cominu-
ing attention to the cardiovascular aspects of he toxic oil
syndrome, in part because of the major puimonan compli-
cations and the later development of a scleroderma-like
illness in many victims. However . it has now been demon-
strated that both arterial and neural abnormalities are exten-
sive in the heart of affected patients who have died (14), and
thin syncope and angina pectoris frequently occur in those
who are severely ill (II,151
. This Seminar was organized to
examine and discuss the basic and clinical features of th^
cardiovascular and neural lesions produced by the toxic )it
syndrome .
Historical Review
From a brief historical review it is apparent that mass
poisoning by various forms of toxic oil, has dotted the paces
of medical annals (16-15), and the epidemic caused by sale
and consumption of adulterated rapeseed oil in Spain i, hat
the most recent example (Table 11 . One of the earliest and in
several respects most representative example is the small
epidemic that occurred in 1937 aboard the French SS lean
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w-a, suspected . Two sailors were admitted to a hospital in
Rotterdam
. The Netherlands . where their symptoms were
recognized as those of tri-ortho-cresyl phosphate poisoning
.
The symptoms of tri-ortho-cresyl phosphate poisoning
h;'d been known since the end of the 19th century 17) but it
out until the toxic epidemic caused by adulterated
Jamaica ginger extract affected a20-000 victims in the
United States in 1930 that the clinical findings became more
widek knottn. Subsequent meticulous analysis of the cir-
cumstances on hoard and the origin of the food products
incriminated the "table oil" brought aboard in Durban .
South Africa as the most likely source . The outbreak of a
,m ;d1 epidemic in Durban appeared to confirm the suspicion .
Alter chemical analysis the presence of cresyl phosphates
,,is first i enied but on reexamination recognized . The report
1171 describing these events demonstrates a classic example
of the complexity of the problems that may be encountered
in toxic epidemics and how these may he resolved by careful
analysis . with critical attention to every available detail . and
by procuring international cooperation . In the 1981 epidemic
in Spain of what is commonly called the toxic oil syndrome,
it has not peen possible to identify precisely the toxic agent .
despise intensive epidemiologic (? .3 .13) and toxicologic (26-
'-9) research . However, it has been established (9) that the
only loo substances consistently present in the toxic oil are
rapeseed oil and oleoanilides, with traces of aniline .
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Table I . Reported Epidemics Caused be toxic Oils'
vascular endothelium (8) . Neither the neural nor the arterial
changes spared the heart (14), but clinical recognition of
cardiac problems has been meager, except for a few rather
indirect ohservations . Pascual-Castrovicjo (11) reported the
presence of angina pectoris-like pain in about 30% of the
chronic cases . This finding suggests the presence of coro-
nary artery disease, but esophageal lesions could also be
responsible for that symptom
. Unspecified electrocardio-
graphic (ECG) abnormalities were found by Kilbourne et al .
(10) in 6 .6%r, of a series of 121 patients but not in those in
whom the disease had a self-limiting course .
Coronary artery disease . The lack of clinical evidence
that coronary artery disease occurs frequently in patients
with the toxic oil syndrome might lead to the conclusion that
this disease is a rare complication of the syndrome . Yet, as
reported by James et al . (14) later in this Seminar, careful
pathologic examination in II cases revealed extensive cor-
onary artery involvement in all 11
. Furthermore. the study
by Gomez-Sanchez et al . (15) in this Seminar describes z
high incidence of syncope and angina pectoris . for which a
cardiac origin at least merits consideration .
Factors obscuring cardiovascular effects. Several factors
may help to explain this apparent lack of attention to the
cardiovascular effects of the toxic oil syndrome . First, many
patients were extremely ill
. In the acute stage they often had
symptoms of extensive pulmonary involvement and in the
later stages other predominant symptoms, including weight
loss
. scleroderma and neurologic symptoms, all making a
diagnosis of concomitant cardiac or coronary artery involve-
ment more difficult . As another factor, the usual anatomic
substrate differed from coronary atherosclerosis in that often
the small arteries were affected in a diffuse manner . In such
cases symptoms are often atypical and may include angina
pectoris . atypical chest pains, congestive heart failure and
arrhythmias. However, these symptoms, if present at all, are
difficult to recognize in severely i11 patients, particularly if
the clinical findings are dominated by symptoms of the acute
'Adapted from Ref.
16. CP = cresyl phosphates: Ref . No. = reference number : TOCP = rri-onho-cresyl
phosphate : TCP = lo-cresyl phosphates .
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respiratory distress syndrome, which may make it impossi-
ble to differentiate between pulmonary and cardiac compo-
nents .
Diagnosis of coronary artery involvement. The develop-
ment of pulmonary hypertension and cor pulmonale may
further obscure the presence of coronary artery involve-
ment. Specific diagnostic tests to demonstrate the presence
of disease of the small coronary arteries are not available .
Electrocardiographic and echocardiographic changes are
nonspecific or absent and in essence the same can be said of
the results of more complicated procedures (such as isotope
exercise tests), which in any event are not suitable for
screening large populations . Even the coronary arterio-
graphic findings will often seem normal because the size of
the vessels involved may be well beyond the resolving power
of angiographic systems (30) .
Diagnostic information about
the small coronary arteries may be obtained from functional
variables such as coronary flow reserve . However, none of
the methods currently available to study coronary flow are
suitable for screening large groups of patients, particularly if
many of the patients are in poor condition (31,32) . Further-
more, even the results of the most accurate tests may he
inconclusive if only a small percentage of the small coronary
arteries are blocked (31-33) .
Purpose of the Seminar
But to return to the certainty of both vascular and neural
pathology throughout the body in victims of the toxic oil
syndrome, and to the meager but important evidence of
clinical cardiovascular problems, the purpose of this Semi-
nar is to present clinical, anatomic, epidemiologic and bio-
chemical observations that we believe merit the attention of
cardiologists and other physicians
. From the onset of the
Spanish tragedy it has been clearly recognized that the
Year Pluto
Ref.
No . Product Tonic Agent
No. of Cases
19]7 SS houn L-0 . °Talde' oil TOCP 24
South .41'rica(Durhan) 41
19417 Germany 14 Torpedo all TOCP
19411 Sm'iteerland II. Machine gun ail TOCP tin
1944
Prince 17 Motor oil TOCP >C
1959 Morale)lMeknesl 18 Lubnrating
,
'Olive"I oil TOCP
(mixed CPI
10.000
19fi11 Bombay 19 Ma-rd oil TOCP 58
19711 Vietnam 20 Helicopter oil TOCPIJ
1977 Sri Lurk . 21 sesame plant oil TCP
tma athtonl
20
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medical, scientific and public health issues at stake reach fir
beyond this epidemic . Optimal understanding of the toxic oil
syndrome will add measurably to our knowledge of the
pathogenesis of many other diseases . including among oth-
ers the hypercosinophilic states, primary pulmonary hyper-
tension, scleroderma and related "collagen diseases" aad
graft-versus-host responses . It is therefore no surprise that
organizations such as the World Health Organization . the
Centers for Communicable Diseases in the United States and
the Medical Research Council of the United Kingdom and
numerous similar public health agencies have conducted
early and continued surveillance of the Spanish toxic oil
syndrome . Perhaps most important of all. the Spanish gov-
ernment itself quickly recognized the global importance and
promptly organized scientific investigation of the epidemic
that continues even today, 10 years after the disaster.
Seminar Presentations
In this Seminar, the initial presentation reviews the : :Irly
and continuing contributions of Kilbourne et at . (34). •.'ho
examined comprehensively the epidemiologic questions in-
volved . Martinez-Tello and Tellez (35) revie,c the extracar-
dine vascular and neural pathology . t o which they called
early attention (8) and now update . James et al . 1141 describe
the extensive abnormalities found in the coronary arteries,
conduction system and neural structure of the heart in
victims of the toxic oil syndrome . As discussed earlier, a
major clinical problem has been pulmonary vascular disease,
a subject of early (6) and continuing investigation by Gomez-
Sanchez et al . (15) . Finally, recent investigations of the
biochemical basis of vasculotoxic agents, including those
related to the toxic oil syndrome, are reviewed by Boor et al .
(36) .
Implications. Although the acute phase of the toxic oil
syndrome has long passed, and the chronic effect, seem to
be waning or at least are increasingly difficult to distinguish
from unrelated morbidity and mortality more than a decade
after the epidemic, the lessons to be learned are timeless and
have broad implications of which many readers are unaware.
For example, the two anatomic abnormalities in the heart-
the damage to coronary arteries and to neural strnetules-
may have effects for many more years and possibly will
cause greater clinical problems with the passage of time .
Finally, there is the stark reminder introduced by the more
recent eosinophilia-myalgia syndrome 137-44) that we have
not seen the last of such epidemics, some of which have
strikingly similar clinical and pathologic effects despite
seemingly very different types of poisoning.
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